Trial Search Results
Diagnostic Utility of MRI in Intracerebral Hemorrhage
The overall aim of this project is to prospectively determine whether MRI can improve the conventional neuroradiological evaluation (CT with or without cerebral angiography) of patients with a spontaneous ICH or IVH. The study design will also allow us to identify the added benefit of specific MR sequences and repeat MRI in the chronic stage, thereby allowing us to prospectively determine their value in a consecutive series of patients. This information should have a major impact on the management of these patients by providing data on the diagnostic yield of routine MRI in patients presenting with a wide variety of causes for ICH or IVH. These data will help guide the diagnostic evaluation and the management of brain hemorrhage patients in the future.
Stanford is currently not accepting patients for this trial.
A. Men and non-pregnant women, at least 18 years of age.
B. Patients with an ICH or IVH admitted to Stanford University Medical center within 48
hours of symptom onset.
C. Ability to undergo MRI.
A. Patients with a known (preexisting) source for ICH, for example a known untreated
B. Patients receiving investigational drug therapies or procedures prior to MRI scanning.
C. Glasgow coma scale (GCS) score < 6 in the absence of sedating medications.
D. Informed consent cannot be obtained either directly from the patient or from a legally
E. Severe coexisting or terminal systemic disease that limits life expectancy or that may
interfere with the conduct of the study
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study